Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Raltrox Injection is used to relieve moderate to severe pain, including pain associated with myocardial infarction (MI). It can also be given alongside balanced anesthesia, for pain control before and after surgery, and for pain relief during labor and delivery.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Nalbuphine Hydrochloride is a potent synthetic analgesic, with pain-relieving strength essentially equal to that of morphine on a milligram-for-milligram basis. Receptor studies show that it binds to mu, kappa, and delta receptors, but not to sigma receptors, acting primarily as a kappa agonist with partial mu-antagonist activity. Given intravenously, it starts working within 2 to 3 minutes; given subcutaneously or intramuscularly, it takes effect in under 15 minutes. Its plasma half-life is about 5 hours, and clinical studies have found its pain-relieving effect to last anywhere from 3 to 6 hours.

Pregnancy & Breastfeeding

Pregnancy category B. Nalbuphine crosses the placenta readily and quickly, and there are no well-controlled studies in pregnant women, so it should be used in pregnancy only when clearly needed. Limited data show that small amounts pass into breast milk (under 1% of the maternal dose), with no expected clinical effect on the infant; even so, caution is advised when giving Nalbuphine to a breastfeeding woman.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: The usual recommended adult dose is 10 mg for a 70 kg individual, given by intramuscular or intravenous injection; this dose may be repeated every 3 to 6 hours as necessary. Dosage should be adjusted according to the severity of the pain, the physical condition of the patient, and other medications the patient may be receiving. For moderate to severe pain, the intravenous or intramuscular dose is 10 to 20 mg for a 70 kg patient, adjusted as required; for a child, up to 0.3 mg/kg, repeated once or twice as necessary. For preoperative anesthesia, the intravenous or intramuscular dose is 0.1 to 0.2 mg/kg. For obstetrical analgesia during labor and delivery, the intravenous dose is 0.3 to 1 mg/kg given over 10 to 15 minutes, with maintenance doses of 0.25 to 0.5 mg/kg given as a single intravenous administration as required. For intraoperative analgesia, the intravenous dose is 0.25 to 0.5 mg/kg at 30 minute intervals. For myocardial infarction, the dose is 10 to 20 mg by slow intravenous injection, repeated after 30 minutes if necessary. A larger dose is required when nalbuphine is used as a supplement to anesthesia than when it is used for analgesia alone. For children from 18 months to 15 years old, the usual dose is 0.2 mg/kg body weight, given preferably by intravenous or intramuscular injection. Maintenance doses may be given at intervals of 4 to 6 hours, or the dose may be determined by the physician.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.